Oncology & Cancer

Reducing the side effects of treatment for prostate cancer

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen ...

Oncology & Cancer

Coffee may help prevent breast cancer returning, study finds

Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups ...

Medical research

Targeting ion channels to manage osteoarthritis pain

Therapeutically targeting ion channels in nociceptor neurons may be a promising strategy to manage osteoarthritis pain, according to a Northwestern Medicine study published in Cell Reports.

Medical research

Existing drug may help fight the lethality of E. coli infection

Stopping the spread of Shiga toxins released by E. coli bacteria, which are potentially fatal if they reach the kidneys, has been a focus of researchers for years. No treatments for STEC currently exist, and antibiotic therapy ...

Oncology & Cancer

Scientists link gene to tamoxifen-resistant breast cancers

After mining the genetic records of thousands of breast cancer patients, researchers from the Johns Hopkins Kimmel Cancer Center have identified a gene whose presence may explain why some breast cancers are resistant to tamoxifen, ...

Oncology & Cancer

Risk of death from breast cancer higher among older patients

Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher risk of death from breast cancer, according to a study in the February 8 issue of JAMA.

Oncology & Cancer

Two years of tamoxifen offers long-term survival benefit

(HealthDay)—For premenopausal women with breast cancer, two years of tamoxifen is associated with long-term survival benefit, according to a study published online May 9 in the Journal of Clinical Oncology.

page 5 from 15